Revisiting the seed and soil in cancer metastasis.

Metastasis remains the overwhelming cause of death for cancer patients. During metastasis, cancer cells will leave the primary tumor, intravasate into the bloodstream, arrest at a distant organ, and eventually develop into gross lesions at the secondary sites. This intricate process is influenced by innumerable factors and complex cellular interactions described in 1889 by Stephen Paget as the seed and soil hypothesis. In this review, we revisit this seed and soil hypothesis with an emerging understanding of the cancer cell (i.e. seed) and its microenvironment (i.e. soil). We will provide background to suggest that a critical outcome of the seed-soil interaction is resistance of the stresses that would otherwise impede metastasis.

[1]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[2]  B. Brüne,et al.  Regulation of the Hypoxia-inducible Factor 1α by the Inflammatory Mediators Nitric Oxide and Tumor Necrosis Factor-α in Contrast to Desferroxamine and Phenylarsine Oxide* , 2001, The Journal of Biological Chemistry.

[3]  M. Nakajima,et al.  The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762nf mammary adenocarcinoma cells , 1988, International journal of cancer.

[4]  F. Mitjans,et al.  αvβ5-Integrins mediate early steps of metastasis formation , 2005 .

[5]  R. Wiltrout,et al.  Modulation of formation of tumor metastases by peritoneal macrophages elicited by various agents , 2004, Cancer Immunology, Immunotherapy.

[6]  M. Pagano,et al.  Prognostic Value of Intratumoral Neutrophils in Advanced Gastric Carcinoma in a High-Risk Area in Northern Italy , 2002, Modern Pathology.

[7]  G. Nilsson,et al.  Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. , 2007, Cancer research.

[8]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[9]  J. Cawley,et al.  The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. , 2002, Blood.

[10]  G. Karakiulakis,et al.  Inhibition of angiogenesis, tumour growth and metastasis by the NO‐releasing vasodilators, isosorbide mononitrate and dinitrate , 1995, British journal of pharmacology.

[11]  Kathryn E Luker,et al.  Functions of CXCL12 and CXCR4 in breast cancer. , 2006, Cancer letters.

[12]  M. Sporn,et al.  Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. , 1986, Journal of immunology.

[13]  Y. Doki,et al.  Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus , 1999, Cancer.

[14]  A. Oshima,et al.  Reciprocal Modifications of CLIC4 in Tumor Epithelium and Stroma Mark Malignant Progression of Multiple Human Cancers , 2007, Clinical Cancer Research.

[15]  N. Hynes,et al.  Ablation of β1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation , 2005, The Journal of cell biology.

[16]  S. Groshen,et al.  Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. , 2008, Cancer research.

[17]  J. Boonstra,et al.  Regulation of G1 phase progression by growth factors and the extracellular matrix , 2001, Cellular and Molecular Life Sciences CMLS.

[18]  R. Hill,et al.  An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells , 1997, Clinical & Experimental Metastasis.

[19]  W. Hiddemann,et al.  Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. , 1997, Anticancer research.

[20]  Simon C Watkins,et al.  Nitric Oxide and Ionizing Radiation Synergistically Promote Apoptosis and Growth Inhibition of Cancer by Activating p53 , 2004, Cancer Research.

[21]  Michael Loran Dustin,et al.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.

[22]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[23]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[24]  K. Nagashima,et al.  The Organellular Chloride Channel Protein CLIC4/mtCLIC Translocates to the Nucleus in Response to Cellular Stress and Accelerates Apoptosis* , 2004, Journal of Biological Chemistry.

[25]  D. Carbone,et al.  Tumor-host immune interactions and dendritic cell dysfunction. , 2004, Advances in cancer research.

[26]  J. Haier,et al.  Integrins in cancer treatment. , 2006, Current cancer drug targets.

[27]  E. Williams,et al.  Expression and localization of GLUT1 and GLUT12 in prostate carcinoma , 2003, Cancer.

[28]  G. Stassi,et al.  Cancer stem cells – old concepts, new insights , 2008, Cell Death and Differentiation.

[29]  C. Brigati,et al.  Tumors and inflammatory infiltrates: Friends or foes? , 2004, Clinical & Experimental Metastasis.

[30]  L. Liotta,et al.  Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.

[31]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[32]  R. Juliano,et al.  Clinging to life: cell to matrix adhesion and cell survival , 2005, Cancer and Metastasis Reviews.

[33]  J. Schuetz,et al.  The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme* , 2004, Journal of Biological Chemistry.

[34]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[35]  H. Wiley,et al.  Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. , 2001, Journal of the National Cancer Institute.

[36]  Masahiro Inoue,et al.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.

[37]  C. Osborne,et al.  Targeting the EGF receptor in breast cancer treatment , 2004, Breast Cancer Research and Treatment.

[38]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[39]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[40]  M. Bissell,et al.  The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.

[41]  L-M Wu,et al.  MMP2 promoter polymorphism (C‐1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation , 2008, Clinical genetics.

[42]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[43]  T. A. Smith,et al.  Facilitative glucose transporter expression in human cancer tissue. , 1999, British journal of biomedical science.

[44]  C. Harris,et al.  Interactive effects of nitric oxide and the p 53 tumor suppressor gene in carcinogenesis and tumor progression , 2004 .

[45]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[46]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[47]  A. Baron,et al.  Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. , 2008, Biochimica et biophysica acta.

[48]  Hypoxia and oxidative stress in breast cancer: Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer , 2001, Breast Cancer Research.

[49]  M. Imamura,et al.  Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  J. Hecht,et al.  Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  G. Semenza,et al.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.

[52]  H. Kwon,et al.  Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol. , 2002, Molecular pharmacology.

[53]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[54]  W. Birchmeier,et al.  Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.

[55]  J. Best,et al.  Differential expression of GLUT12 in breast cancer and normal breast tissue. , 2003, Cancer letters.

[56]  S. Hayward,et al.  Role of the stromal microenvironment in carcinogenesis of the prostate , 2003, International journal of cancer.

[57]  G. V. Vande Woude,et al.  Autocrine mechanism for met proto-oncogene tumorigenicity. , 1994, Cold Spring Harbor symposia on quantitative biology.

[58]  V. Haase,et al.  The VHL tumor suppressor and HIF: insights from genetic studies in mice , 2008, Cell Death and Differentiation.

[59]  Beverly A. Teicher,et al.  Transforming Growth Factor-β and the Immune Response to Malignant Disease , 2007, Clinical Cancer Research.

[60]  B. Wouters,et al.  Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin , 1999, British Journal of Cancer.

[61]  Yi-Chen Lin,et al.  Tumor-associated macrophages: the double-edged sword in cancer progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  M. Makuuchi,et al.  Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. , 2000, Blood.

[63]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[64]  R. Dickson,et al.  EGF receptor in breast cancer chemoresistance. , 2007, Advances in experimental medicine and biology.

[65]  K. Syrigos,et al.  Clinical significance of heat shock protein-70 expression in bladder cancer. , 2003, Urology.

[66]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[67]  Monique Martin,et al.  Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. , 1996, Pathology, research and practice.

[68]  C. Roland,et al.  ICAM-1 expression determines malignant potential of cancer. , 2007, Surgery.

[69]  Michael F Clarke,et al.  The biology of cancer stem cells. , 2007, Annual review of cell and developmental biology.

[70]  T. Yamano,et al.  CCL21 Chemokine Regulates Chemokine Receptor CCR7 Bearing Malignant Melanoma Cells , 2004, Clinical Cancer Research.

[71]  M. Melamed,et al.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[72]  R. Wechsler-Reya,et al.  Hit 'em where they live: targeting the cancer stem cell niche. , 2007, Cancer cell.

[73]  T. Ishida,et al.  Expression of heat shock proteins in osteosarcoma and its relationship to prognosis. , 2000, Pathology, research and practice.

[74]  R. Pearcey,et al.  A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer. , 2000, International journal of radiation oncology, biology, physics.

[75]  P. Hein,et al.  Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.

[76]  D. Welch,et al.  Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Gavin Sherlock,et al.  Isolation and Molecular Characterization of Cancer Stem Cells in MMTV‐Wnt‐1 Murine Breast Tumors , 2008, Stem cells.

[78]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[79]  J. Talmadge,et al.  Clonal selection of metastasis within the life history of a tumor. , 2007, Cancer research.

[80]  Harold Varmus,et al.  Seeding and Propagation of Untransformed Mouse Mammary Cells in the Lung , 2008, Science.

[81]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[82]  M. Caligiuri,et al.  Interleukin-2, interleukin-15, and their roles in human natural killer cells. , 2005, Advances in immunology.

[83]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[84]  T. Whiteside,et al.  Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[85]  D. Leroith,et al.  The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.

[86]  Amy S. Lee,et al.  Glucose regulated proteins in cancer progression, Drug resistance and immunotherapy , 2006, Cancer biology & therapy.

[87]  S. Yuspa,et al.  p53 and Tumor Necrosis Factor α Regulate the Expression of a Mitochondrial Chloride Channel Protein* , 1999, The Journal of Biological Chemistry.

[88]  Brian Keith,et al.  Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.

[89]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.

[90]  A. Theocharis,et al.  The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer. , 2007, Current medicinal chemistry.

[91]  G. Trinchieri,et al.  Regulation of NK cell functions by TGF-beta 1. , 1995, Journal of immunology.

[92]  J. Massagué,et al.  Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.

[93]  Barry Halliwell,et al.  Oxidative stress and cancer: have we moved forward? , 2007, The Biochemical journal.

[94]  S. Iida,et al.  The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma , 2006, Leukemia.

[95]  B. Fingleton,et al.  Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. , 2008, Cancer research.

[96]  R. Midura,et al.  Activation of Integrin αVβ3 Regulates Cell Adhesion and Migration to Bone Sialoprotein , 2000 .

[97]  I. Weissman,et al.  Therapeutic implications of cancer stem cells. , 2004, Current opinion in genetics & development.

[98]  G. Pawelec.  Tumour escape: antitumour effectors too much of a good thing? , 2004, Cancer Immunology, Immunotherapy.

[99]  Brian Bierie,et al.  Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer , 2006, Nature Reviews Cancer.

[100]  L. Borsig.  The role of platelet activation in tumor metastasis , 2008, Expert review of anticancer therapy.

[101]  F. Giancotti,et al.  Integrin β4 signaling promotes tumor angiogenesis , 2004 .

[102]  Thomas C. Chen,et al.  The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. , 2007, Cancer research.

[103]  C. Hill,et al.  Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. , 2006, Cytokine & growth factor reviews.

[104]  G. Stamp,et al.  Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. , 1997, The American journal of pathology.

[105]  John Condeelis,et al.  Invadopodia and podosomes in tumor invasion. , 2006, European journal of cell biology.

[106]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[107]  B. Klaunberg,et al.  Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10 , 2003, The Journal of experimental medicine.

[108]  S. Karpatkin,et al.  Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. , 1988, The Journal of clinical investigation.

[109]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[110]  A. Agarwal,et al.  PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.

[111]  P. Burkett,et al.  Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. , 2006, Annual review of immunology.

[112]  A. Steven,et al.  mtCLIC/CLIC4, an Organellular Chloride Channel Protein, Is Increased by DNA Damage and Participates in the Apoptotic Response to p53 , 2002, Molecular and Cellular Biology.

[113]  J. Abbruzzese,et al.  Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. , 2001, Cancer research.

[114]  C. L. La Porta,et al.  Cancer stem cells and therapeutic perspectives. , 2006, Current medicinal chemistry.

[115]  J. Caro,et al.  Hypoxia regulatory elements of the human vascular endothelial growth factor gene. , 1994, Cellular & molecular biology research.

[116]  R. Borojevic,et al.  Breast cancer micrometastases: Different interactions of carcinoma cells with normal and cancer patients' bone marrow stromata , 2004, Clinical & Experimental Metastasis.

[117]  E. Surmacz,et al.  Crosstalk between IGF signaling and steroid hormone receptors in breast cancer. , 2007, Current pharmaceutical design.

[118]  G. Owen,et al.  Glucose transporters: expression, regulation and cancer. , 2002, Biological research.

[119]  I. Haznedaroglu,et al.  How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems. , 2004, Medical hypotheses.

[120]  R. Weber,et al.  ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion! , 2005, Oral oncology.

[121]  E. Liu,et al.  Genetic background is an important determinant of metastatic potential , 2003, Nature Genetics.

[122]  Ulrich Keilholz,et al.  Immunohistochemical analysis of integrin αvβ3 expression on tumor‐associated vessels of human carcinomas , 1997 .

[123]  L. Magnelli,et al.  Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor‐C expression in head and neck squamous cell carcinoma , 2006, The Journal of pathology.

[124]  M. Simon,et al.  Metastasis and stem cell pathways , 2007, Cancer and Metastasis Reviews.

[125]  A. Seiyama,et al.  Effects of NG-nitro-L-arginine and/or L-arginine on experimental pulmonary metastasis in mice. , 1994, Cancer letters.

[126]  Soldano Ferrone,et al.  Clinical Significance of αvβ3 Integrin and Intercellular Adhesion Molecule-1 Expression in Cutaneous Malignant Melanoma Lesions , 1997 .

[127]  F. Tanaka,et al.  Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. , 2002, Cancer research.

[128]  Anthony J. Guidi,et al.  Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[129]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[130]  T. Bieber,et al.  Circulating clonal CLA+ and CD4+ T cells in Sézary syndrome express the skin‐homing chemokine receptors CCR4 and CCR10 as well as the lymph node‐homing chemokine receptor CCR7 , 2005, The British journal of dermatology.

[131]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[132]  E. Lengyel,et al.  The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. , 2008, The Journal of clinical investigation.

[133]  G. Dranoff,et al.  CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte–macrophage colony-stimulating factor-dependent fashion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[134]  R. Hill,et al.  Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[135]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[136]  K. Hirata,et al.  Separate functions of α2β1 and α2β1 integrins in the metastatic process of human gastric carcinomaintegrins in the metastatic process of human gastric carcinoma , 2006, Surgery Today.

[137]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[138]  Kiyoshi Maeda,et al.  Up regulation of ICAM-1 gene expression inhibits tumour growth and liver metastasis in colorectal carcinoma. , 2005, European journal of cancer.

[139]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[140]  G. Casey,et al.  Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1 , 2008, International journal of cancer.

[141]  Philipp Busch,et al.  Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. , 2005, Journal of the National Cancer Institute.

[142]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[143]  P. Glazer,et al.  Genetic instability induced by the tumor microenvironment. , 1996, Cancer research.

[144]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[145]  C. Arteaga.  EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans. , 2006, Cancer cell.

[146]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[147]  D. Johnston,et al.  Heterogeneity in induced heat resistance and its relation to synthesis of stress proteins in rat tumor cell clones. , 1984, Cancer research.

[148]  U. Lendahl,et al.  Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.

[149]  D. Cheresh,et al.  Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin. , 1992, The Journal of clinical investigation.

[150]  R. Kaplan,et al.  Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond , 2007, Cancer and Metastasis Reviews.

[151]  R L Juliano,et al.  Adhesion molecules in cancer: the role of integrins. , 1993, Current opinion in cell biology.

[152]  Carol Cass,et al.  Nitric Oxide and Cyclic GMP Increase the Expression of Matrix Metalloproteinase-9 in Vascular Smooth Muscle , 2003, Journal of Pharmacology and Experimental Therapeutics.

[153]  C. Chi,et al.  Prognostic significance of heat shock protein‐27 expression in hepatocellular carcinoma and its relation to histologic grading and survival , 2000, Cancer.

[154]  I. Fariñas,et al.  Pigment epithelium–derived factor is a niche signal for neural stem cell renewal , 2006, Nature Neuroscience.

[155]  W. Wiktor-Jedrzejczak,et al.  Impaired tumor growth in colony‐stimulating factor 1 (CSF‐1)‐deficient, macrophage‐deficient op/op mouse: Evidence for a role of CSF‐1‐dependent macrophages in formation of tumor stroma , 1996, International journal of cancer.

[156]  Ge Zhou,et al.  Expression of intercellular adhesive molecule-1 in liver cancer tissues andliver cancer metastasis. , 1998, World journal of gastroenterology.

[157]  Hong Zhang,et al.  Targeting multiple signal transduction pathways through inhibition of Hsp90 , 2004, Journal of Molecular Medicine.

[158]  A. Smits,et al.  Platelet-derived growth factor (PDGF) in primary brain tumours of neuroglial origin. , 1998, Histology and histopathology.

[159]  H. Lee,et al.  EGF/ErbB receptor family in ovarian cancer. , 2002, Cancer treatment and research.

[160]  S. Moncada,et al.  Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. , 1991, Cancer research.

[161]  W. Guo,et al.  Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. , 2004, Carcinogenesis.

[162]  Allan Balmain,et al.  TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.

[163]  S. Kitazawa,et al.  Integrin αvβ3 Expression by Bone‐residing Breast Cancer Metastases , 1996 .

[164]  T. Danielsen,et al.  Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis , 1999, British Journal of Cancer.

[165]  Wenjun Guo,et al.  Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.

[166]  R. Wiltrout,et al.  Augmentation of metastasis formation by thioglycollate‐elicited macrophages , 1982, International journal of cancer.

[167]  F. Nestle,et al.  Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. , 2002, Cancer research.

[168]  Misa Nakamura,et al.  Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[169]  M. Higashiyama,et al.  NG‐Nitro‐L‐arginine Methyl Ester Inhibits Bone Metastasis after Modified Intracardiac Injection of Human Breast Cancer Cells in a Nude Mouse Model , 1997, Japanese journal of cancer research : Gann.

[170]  Robert Gray,et al.  Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. , 2006, The New England journal of medicine.

[171]  T. Fojo,et al.  The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy , 2001, Leukemia.

[172]  V. Stein,et al.  Molecular structure and physiological function of chloride channels. , 2002, Physiological reviews.

[173]  I. Witz,et al.  The tumor microenvironment in the post-PAGET era. , 2006, Cancer letters.

[174]  M. Younes,et al.  Immunohistochemical detection of glut 3 in human tumors and normal tissues , 1997 .

[175]  C. Bucana,et al.  Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma. , 2006, The American journal of pathology.

[176]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[177]  J. Chirgwin,et al.  A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[178]  Liang Zhao,et al.  Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins , 2007, Journal of Cancer Research and Clinical Oncology.

[179]  A. Sica,et al.  A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter , 1995, The Journal of experimental medicine.

[180]  G. Taraboletti,et al.  Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion , 2008, Molecular Cancer Research.

[181]  C. Bucana,et al.  Expression of activated platelet‐derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential , 2006, International journal of cancer.

[182]  D. Schadendorf,et al.  Functional CCR9 expression is associated with small intestinal metastasis. , 2004, The Journal of investigative dermatology.

[183]  C. Heldin,et al.  Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[184]  P. Steeg,et al.  Metastasis: a therapeutic target for cancer , 2008, Nature Clinical Practice Oncology.

[185]  S. Wahl,et al.  TGF‐β: a mobile purveyor of immune privilege , 2006 .

[186]  B. Paule.  [Potential therapeutic implications of EGF R/PDGF R signalling pathways in bone metastases of prostate cancer]. , 2005, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[187]  R. Weinberg,et al.  Adaptation versus selection: the origins of metastatic behavior. , 2007, Cancer research.

[188]  S. Kostyk,et al.  Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. , 1994, The American journal of physiology.

[189]  W. Schürch,et al.  Myofibroblasts in the stroma of invasive and metastatic carcinoma A possible host response to neoplasia , 1979, The American journal of surgical pathology.

[190]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[191]  R L Juliano,et al.  Cell adhesion molecules, signal transduction and cell growth. , 1999, Current opinion in cell biology.

[192]  I. Takanami.  Overexpression of CCR7 mRNA in nonsmall cell lung cancer: Correlation with lymph node metastasis , 2003, International journal of cancer.

[193]  S. Segerer,et al.  CCR10 is expressed in cutaneous T‐cell lymphoma , 2005, International journal of cancer.

[194]  S. Ferrone,et al.  Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. , 1990, Cancer research.

[195]  S. Fang,et al.  Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer , 2007, Clinical & Experimental Metastasis.

[196]  S. Monti,et al.  The IGF axis in prostate cancer. , 2007, Current pharmaceutical design.

[197]  F. Orr,et al.  Interactions of cancer cells with the microvasculature during metastasis 1 2 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[198]  N. Maulik,et al.  Redox signaling in vascular angiogenesis. , 2002, Free radical biology & medicine.

[199]  George Stoica,et al.  Expression of MMP2, MMP9 and MMP3 in Breast Cancer Brain Metastasis in a Rat Model , 2005, Clinical & Experimental Metastasis.

[200]  A. Seiyama,et al.  Increase in experimental pulmonary metastasis in mice by L‐arginine under inhibition of nitric oxide production by NG‐nitro‐L‐arginine methyl ester , 1998, International journal of cancer.

[201]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[202]  A. Toker,et al.  Akt signaling and cancer: surviving but not moving on. , 2006, Cancer research.

[203]  Max S Wicha,et al.  Cancer stem cells: an old idea--a paradigm shift. , 2006, Cancer research.

[204]  D. Hedley,et al.  Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. , 1998, International journal of radiation oncology, biology, physics.

[205]  P. Kurschat,et al.  Mechanisms of metastasis , 2000, Clinical and experimental dermatology.

[206]  I. Fidler,et al.  Therapy of cancer metastasis by activation of the inducible nitric oxide synthase , 1998, Cancer and Metastasis Reviews.

[207]  A. Lièvre,et al.  Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma , 2006, BMC Cancer.

[208]  Stephen M Hewitt,et al.  The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis , 2004, Nature Medicine.

[209]  M. Sütterlin,et al.  Heat-shock protein 70 as a prognostic marker in node-negative breast cancer. , 2003, Anticancer research.

[210]  S. Sommer,et al.  EGF Receptor Testing for Non‐Small Cell Lung Carcinomas , 2006, Current protocols in human genetics.

[211]  H. von Boehmer,et al.  The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. , 2006, Seminars in cancer biology.

[212]  Sally Temple,et al.  Endothelial Cells Stimulate Self-Renewal and Expand Neurogenesis of Neural Stem Cells , 2004, Science.

[213]  L. Trusolino,et al.  Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis. , 2005, Cancer research.

[214]  M. Yashiro,et al.  ICAM-2 Gene Therapy for Peritoneal Dissemination of Scirrhous Gastric Carcinoma , 2004, Clinical Cancer Research.

[215]  Javed Khan,et al.  Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators , 2004, Nature Medicine.

[216]  E. Maiorano,et al.  The IGF-I axis in thyroid carcinoma. , 2007, Current pharmaceutical design.

[217]  K. W. Kim,et al.  Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. , 1998, Cancer research.

[218]  Andrew V. Nguyen,et al.  The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression , 2002, Journal of Mammary Gland Biology and Neoplasia.

[219]  M. Gerdes,et al.  Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth. , 2005, Cancer research.

[220]  I. Hart,et al.  Integrin trafficking and its role in cancer metastasis , 2007, Cancer and Metastasis Reviews.

[221]  John Condeelis,et al.  Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.

[222]  Adrian L Harris,et al.  Hypoxia and oxidative stress in breast cancer: Hypoxia and tumourigenesis , 2001, Breast Cancer Research.

[223]  P. Comoglio,et al.  Invasive growth: a MET-driven genetic programme for cancer and stem cells , 2006, Nature Reviews Cancer.

[224]  I. Fidler,et al.  Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. , 2002, Journal of the National Cancer Institute.

[225]  R. Xavier,et al.  Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.

[226]  L. Trusolino,et al.  β4 integrin activates a Shp2–Src signaling pathway that sustains HGF-induced anchorage-independent growth , 2006, The Journal of cell biology.

[227]  Amy S. Lee,et al.  GRP78/BiP Is Required for Cell Proliferation and Protecting the Inner Cell Mass from Apoptosis during Early Mouse Embryonic Development , 2006, Molecular and Cellular Biology.

[228]  J. Aguirre-Ghiso,et al.  Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. , 2006, Cancer research.

[229]  A. Allan,et al.  Cancer stem cells: implications for the progression and treatment of metastatic disease , 2007, Journal of cellular and molecular medicine.

[230]  Stefan Kammerer,et al.  Role of ICAM1 in invasion of human breast cancer cells. , 2005, Carcinogenesis.

[231]  H. Lyng,et al.  Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis , 2000, British Journal of Cancer.

[232]  J. Shay,et al.  Hypoxia-Inducible Factor 1 Mediates Upregulation of Telomerase (hTERT) , 2004, Molecular and Cellular Biology.

[233]  I. Fidler,et al.  Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. , 2007, Endocrine reviews.

[234]  F. Strutz,et al.  Role of fibroblast activation in inducing interstitial fibrosis. , 2000, Journal of nephrology.

[235]  D. Scadden,et al.  The stem-cell niche as an entity of action , 2006, Nature.

[236]  Suyun Huang,et al.  Regulation of cancer metastasis by stress pathways , 2004, Clinical & Experimental Metastasis.

[237]  J. Norman,et al.  Integrin Trafficking and the Control of Cell Migration , 2006, Traffic.

[238]  P. Oettgen,et al.  Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. , 2005, The Journal of clinical investigation.

[239]  J. Bonner,et al.  EGF and PDGF receptor tyrosine kinases as therapeutic targets for chronic lung diseases. , 2006, Current molecular medicine.

[240]  Shailesh Singh,et al.  Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and Invasion , 2004, Clinical Cancer Research.

[241]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[242]  Y. Yarden,et al.  Sensitivity of Mature ErbB2 to Geldanamycin Is Conferred by Its Kinase Domain and Is Mediated by the Chaperone Protein Hsp90* , 2001, The Journal of Biological Chemistry.